rs201453600
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_003239.5(TGFB3):āc.412T>Gā(p.Ser138Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003239.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFB3 | NM_003239.5 | c.412T>G | p.Ser138Ala | missense_variant | Exon 2 of 7 | ENST00000238682.8 | NP_003230.1 | |
TGFB3 | NM_001329939.2 | c.412T>G | p.Ser138Ala | missense_variant | Exon 3 of 8 | NP_001316868.1 | ||
TGFB3 | NM_001329938.2 | c.412T>G | p.Ser138Ala | missense_variant | Exon 2 of 5 | NP_001316867.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251440Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135894
GnomAD4 exome AF: 0.000156 AC: 228AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.000157 AC XY: 114AN XY: 727248
GnomAD4 genome AF: 0.000164 AC: 25AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74384
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:2
- -
The TGFB3 c.412T>G; p.Ser138Ala variant (rs201453600; ClinVar Variation ID: 239520) is reported in the literature in an individual affected with a suspected heritable thoracic aortic disorder, although its clinical significance was not certain (Overwater 2018). This variant was also reported in an individual with arrhythmogenic cardiomyopathy but was also identified in a healthy control (Goudal 2022). This variant is observed in the non-Finnish European population with an overall allele frequency of 0.02% (32/129150 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses predict that this variant is neutral (REVEL: 0.066). However, due to limited information, the clinical significance of the p.Ser138Ala variant is uncertain at this time. References: Goudal A et al. Burden of rare variants in arrhythmogenic cardiomyopathy with right dominant form-associated genes provides new insights for molecular diagnosis and clinical management. Hum Mutat. 2022 Sep;43(9):1333-1342. PMID: 35819174. Overwater E et al. Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders. Hum Mutat. 2018 Sep;39(9):1173-1192. PMID: 29907982. -
- -
- -
TGFB3: BP4 -
See Variant Classification Assertion Criteria. -
Rienhoff syndrome Uncertain:2
This sequence change replaces serine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 138 of the TGFB3 protein (p.Ser138Ala). This variant is present in population databases (rs201453600, gnomAD 0.03%). This missense change has been observed in individual(s) with TGFB3-related disease (PMID: 29907982). ClinVar contains an entry for this variant (Variation ID: 239520). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt TGFB3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
not specified Benign:1
Variant summary: TGFB3 c.412T>G (p.Ser138Ala) results in a conservative amino acid change located in the TGF-beta, propeptide domain of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 251440 control chromosomes, predominantly at a frequency of 0.00024 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 24 fold of the estimated maximal expected allele frequency for a pathogenic variant in TGFB3 causing Arrhythmia phenotype (1e-05). c.412T>G has been observed in individual(s) affected with Arrhythmia. These report(s) do not provide unequivocal conclusions about association of the variant with Arrhythmia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 239520). Based on the evidence outlined above, the variant was classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at